Compare Stocks

→ Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABCN VIVO Cannabis	C$1.32 +5.6%	C$1.32	C$0.80 ▼ C$4.06	C$256.62M	N/A	1.51 million shs	310,601 shs
ATTBF Abattis Bioceuticals		$0.00	$0.00 ▼ $0.00	N/A	N/A	11,650 shs	2,500 shs
MTFB MOTIF BIO PLC/S	$0.11	$0.10	$0.08 ▼ $11.50	N/A	N/A	N/A	867,698 shs
VAL Valaris	$69.20 +2.1%	$69.58	$54.13 ▼ $78.92	$5.01B	1.13	868,378 shs	455,759 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABCN VIVO Cannabis	0.00%	0.00%	0.00%	0.00%	0.00%
ATTBF Abattis Bioceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
MTFB MOTIF BIO PLC/S	0.00%	0.00%	0.00%	0.00%	0.00%
VAL Valaris	+0.41%	+1.04%	-5.86%	-1.41%	+15.47%

Move Your Money Before May 22 (Ad)

The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.

Here's where Dr. David Eifrig says to move your money immediately.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VAL Valaris	3.3304 of 5 stars	3.5	1.0	0.0	0.0	2.5	1.7	3.1

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A
VAL Valaris	3.00	Buy	$100.00	44.51% Upside

Current Analyst Ratings

Latest VAL, MTFB, ATTBF, and ABCN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/5/2024	VAL Valaris	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$105.00 ➝ $102.00
2/23/2024	VAL Valaris	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$107.00 ➝ $105.00
2/14/2024	VAL Valaris	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$106.00 ➝ $105.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A	N/A
VAL Valaris	$1.78B	2.81	$2.59 per share	26.72	$27.40 per share	2.53

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABCN VIVO Cannabis	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	-$0.16	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
VAL Valaris	$865.40M	$11.69	5.92	6.67	N/A	48.50%	5.71%	2.40%	5/2/2024 (Confirmed)

Latest VAL, MTFB, ATTBF, and ABCN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/2/2024	N/A	VAL Valaris	$0.40	N/A	-$0.40	N/A	N/A	N/A
2/21/2024	Q4 2023	VAL Valaris	$0.29	$0.61	+$0.32	-$10.08	$484.00 million	$483.80 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A
VAL Valaris	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABCN VIVO Cannabis	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A
VAL Valaris	0.54	1.71	1.71

Ownership

Institutional Ownership

Company	Institutional Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	32.45%
MTFB MOTIF BIO PLC/S	N/A
VAL Valaris	96.74%

Insider Ownership

Company	Insider Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	N/A
MTFB MOTIF BIO PLC/S	N/A
VAL Valaris	0.11%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABCN VIVO Cannabis	N/A	194.41 million	N/A	Not Optionable
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	Not Optionable
MTFB MOTIF BIO PLC/S	7	N/A	N/A	Not Optionable
VAL Valaris	5,985	72.41 million	72.33 million	Optionable

VAL, MTFB, ATTBF, and ABCN Headlines

Source	Headline
	Valaris Limited (NYSE:VAL) Given Consensus Recommendation of "Buy" by Analysts americanbankingnews.com - April 26 at 3:08 AM
	Valaris (NYSE:VAL) Upgraded by StockNews.com to "Sell" americanbankingnews.com - April 26 at 2:18 AM
	Equinor rolls up its sleeves for imminent Argentina exploration well upstreamonline.com - April 25 at 9:14 AM
	Valaris (VAL) Set to Announce Quarterly Earnings on Thursday americanbankingnews.com - April 25 at 2:32 AM
	Louisiana State Employees Retirement System Takes $1.21 Million Position in Valaris Limited (NYSE:VAL) marketbeat.com - April 23 at 4:51 AM
	John Fredriksen ally wins seat on board of potential takeover target International Seaways tradewindsnews.com - April 18 at 10:48 PM
	Valaris Limited (NYSE:VAL) Shares Sold by River Road Asset Management LLC marketbeat.com - April 18 at 9:34 AM
	Interocean announces UT technology demonstration zawya.com - April 16 at 8:33 AM
	Mutual of America Capital Management LLC Acquires 38,367 Shares of Valaris Limited (NYSE:VAL) marketbeat.com - April 14 at 6:11 AM
	Valaris Schedules First Quarter 2024 Earnings Release and Conference Call businesswire.com - April 11 at 4:30 PM
	Aramco Suspends Valaris Rig Contract rigzone.com - April 11 at 1:38 AM
	Valaris (VAL) Receives Rig's Suspension Notice From Aramco zacks.com - April 9 at 2:26 PM
	Lancaster Investment Management Buys Shares of 400,116 Valaris Limited (NYSE:VAL) marketbeat.com - April 9 at 12:12 PM
	Port Everglades marks commissioning of new container cranes en.portnews.ru - April 7 at 11:30 AM
	Valaris faces rig suspension in Saudi joint venture investing.com - April 6 at 2:41 AM
	Aramco Suspends Another Jack-Up Rig oedigital.com - April 5 at 4:40 PM
	Suspension notice for Valaris joint venture royalgazette.com - April 5 at 4:40 PM
	Saudi Aramco suspends offshore rig deal with New York-listed player upstreamonline.com - April 5 at 1:44 AM
	Aramco suspends jackup contract with offshore driller upstreamonline.com - April 4 at 8:43 PM
	Valaris (NYSE:VAL) Shares Gap Down to $76.66 marketbeat.com - April 4 at 2:02 PM
	Valaris Limited (NYSE:VAL) Shares Purchased by Vanguard Group Inc. marketbeat.com - April 3 at 4:09 AM
	Valaris: Buy Despite Near-Term Jackup Market Headwinds seekingalpha.com - April 2 at 7:31 PM
	VAL Quantitative Stock Analysis nasdaq.com - April 1 at 6:26 PM
	Valaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Buy" from Analysts marketbeat.com - April 1 at 4:14 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
5 Cheap Dividend Stocks: Which to Buy Now
April 1, 2024 9:55 AM
View 5 Cheap Dividend Stocks: Which to Buy Now
Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
April 24, 2024 10:40 AM
View Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
3 Value Stocks Buffett Wishes He Could Buy
April 22, 2024 8:35 AM
View 3 Value Stocks Buffett Wishes He Could Buy
ASML’s Earnings Could Bring The Stock to New Highs
April 16, 2024 10:20 AM
View ASML’s Earnings Could Bring The Stock to New Highs

All Headlines

Company Descriptions

VIVO Cannabis

CVE:ABCN

ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.

Abattis Bioceuticals

OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

MOTIF BIO PLC/S

NASDAQ:MTFB

Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.

Valaris

NYSE:VAL

Valaris Limited, together with its subsidiaries, provides offshore contract drilling services Gulf of Mexico, South America, North Sea, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Floaters, Jackups, ARO, and Other. It owns an offshore drilling rig fleet, which include drillships, dynamically positioned semisubmersible rigs, moored semisubmersible rig, and jackup rigs. It serves international, government-owned, and independent oil and gas. Valaris Limited was founded in 1975 and is based in Hamilton, Bermuda.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial